BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23211821)

  • 1. A macrocyclic calpain inhibitor slows the development of inherited cortical cataracts in a sheep model.
    Morton JD; Lee HY; McDermott JD; Robertson LJ; Bickerstaffe R; Jones MA; Coxon JM; Abell AD
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):389-95. PubMed ID: 23211821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain may contribute to hereditary cataract formation in sheep.
    Robertson LJ; Morton JD; Yamaguchi M; Bickerstaffe R; Shearer TR; Azuma M
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4634-40. PubMed ID: 16303960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The involvement of calpains in opacification induced by Ca2+-overload in ovine lens culture.
    Lee HY; Morton JD; Sanderson J; Bickerstaffe R; Robertson LJ
    Vet Ophthalmol; 2008; 11(6):347-55. PubMed ID: 19046274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human lens model of cortical cataract: Ca2+-induced protein loss, vimentin cleavage and opacification.
    Sanderson J; Marcantonio JM; Duncan G
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2255-61. PubMed ID: 10892870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of cataracts and proteolysis in cultured lenses by cysteine protease inhibitor E64.
    Shearer TR; Azuma M; David LL; Murachi T
    Invest Ophthalmol Vis Sci; 1991 Mar; 32(3):533-40. PubMed ID: 1848210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear cataract and light scattering in cultured lenses from guinea pig and rabbit.
    Fukiage C; Azuma M; Nakamura Y; Tamada Y; Shearer TR
    Curr Eye Res; 1998 Jun; 17(6):623-35. PubMed ID: 9663852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of calpain Lp82-induced proteolysis to experimental cataractogenesis in mice.
    Nakamura Y; Fukiage C; Shih M; Ma H; David LL; Azuma M; Shearer TR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1460-6. PubMed ID: 10798663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a novel calpain inhibitor as a treatment for cataract.
    Lee HY; Morton JD; Robertson LJ; McDermott JD; Bickerstaffe R; Abell AD; Jones MA; Mehrtens JM; Coxon JM
    Clin Exp Ophthalmol; 2008 Dec; 36(9):852-60. PubMed ID: 19278481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cell-permeable calpain inhibitors and E64 in reduction of cataract in cultured rat lenses.
    Lampi KJ; Kadoya K; Azuma M; David LL; Shearer TR
    Toxicol Appl Pharmacol; 1992 Nov; 117(1):53-7. PubMed ID: 1440613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallin degradation and insolubilization in regions of young rat lens with calcium ionophore cataract.
    Iwasaki N; David LL; Shearer TR
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):502-9. PubMed ID: 7843919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling, synthesis, and biological evaluation of macrocyclic calpain inhibitors.
    Abell AD; Jones MA; Coxon JM; Morton JD; Aitken SG; McNabb SB; Lee HY; Mehrtens JM; Alexander NA; Stuart BG; Neffe AT; Bickerstaffe R
    Angew Chem Int Ed Engl; 2009; 48(8):1455-8. PubMed ID: 19145612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract and the acceleration of calpain-induced beta-crystallin insolubilization occurring during normal maturation of rat lens.
    David LL; Azuma M; Shearer TR
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):785-93. PubMed ID: 8125740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling: a search for a calpain inhibitor as a new treatment for cataractogenesis.
    Stuart BG; Coxon JM; Morton JD; Abell AD; McDonald DQ; Aitken SG; Jones MA; Bickerstaffe R
    J Med Chem; 2011 Nov; 54(21):7503-22. PubMed ID: 21955158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of various calpain inhibitors in reduction of light scattering, protein precipitation and nuclear cataract in vitro.
    Mathur P; Gupta SK; Wegener AR; Breipohl W; Ahrend MH; Sharma YD; Gupta YK; Vajpayee RB
    Curr Eye Res; 2000 Dec; 21(6):926-33. PubMed ID: 11262616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calpains: targets of cataract prevention?
    Biswas S; Harris F; Dennison S; Singh J; Phoenix DA
    Trends Mol Med; 2004 Feb; 10(2):78-84. PubMed ID: 15102361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of calpain in diamide-induced cataract in cultured lenses.
    Azuma M; Shearer TR
    FEBS Lett; 1992 Aug; 307(3):313-7. PubMed ID: 1644187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calpains: enzymes of vision?
    Biswas S; Harris F; Dennison S; Singh JP; Phoenix D
    Med Sci Monit; 2005 Sep; 11(9):RA301-10. PubMed ID: 16127377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of pirenoxine in the effects of catalin on in vitro ultraviolet-induced lens protein turbidity and selenite-induced cataractogenesis in vivo.
    Hu CC; Liao JH; Hsu KY; Lin IL; Tsai MH; Wu WH; Wei TT; Huang YS; Chiu SJ; Chen HY; Wu SH; Wu TH
    Mol Vis; 2011; 17():1862-70. PubMed ID: 21850160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of calpain-mediated alpha-crystallin proteolysis in the UPL rat hereditary cataract.
    Tomohiro M; Aida Y; Inomata M; Ito Y; Mizuno A; Sakuma S
    Jpn J Ophthalmol; 1997; 41(3):121-9. PubMed ID: 9243307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Broccoli regulates protein alterations and cataractogenesis in selenite models.
    Vibin M; Siva Priya SG; N Rooban B; Sasikala V; Sahasranamam V; Abraham A
    Curr Eye Res; 2010 Feb; 35(2):99-107. PubMed ID: 20136419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.